Numerous authors have demonstrated that polymorphisms in genes encoding DNA glycosylases, such as UNG and POLG, can modify the risk of cancer development in carriers of BRCA1 and BRCA2 mutations, a high-risk group [105,106,107]. This evidence concerns the gene BRCA1 and cancer.